Literature DB >> 10431107

Inaccuracy of Ballard scores before 28 weeks' gestation. National Institute of Child Health and Human Development Neonatal Research Network.

E F Donovan1, J E Tyson, R A Ehrenkranz, J Verter, L L Wright, S B Korones, C R Bauer, S Shankaran, B J Stoll, A A Fanaroff, W Oh, J A Lemons, D K Stevenson, L A Papile.   

Abstract

OBJECTIVE: Ballard scores are commonly used to estimate gestational age (GA). The purpose of this study was to determine the accuracy of the New Ballard Score (NBS) for infants <28 weeks GA by accurate menstrual history and to evaluate NBS as an outcome predictor.
METHODS: Infants weighing 401 to 1500 g in 12 National Institute of Child Health and Human Development Neonatal Research Network centers had NBS performed before age 48 hours. Accuracy of NBS estimates of GA was assessed for infants with GA determined by accurate menstrual history. In a larger cohort of infants, NBS was included in regression models of the association of NBS and death, poor outcome, and duration of hospital stay.
RESULTS: At each week from 22 to 28 weeks GA by accurate menstrual history, NBS estimates exceeded GA by dates by 1.3 to 3.3 weeks, and estimates varied widely (range of widths of 95% CIs for the observations, 6.8 to 11.9 weeks). NBS did not contribute significantly to regression models of death, poor outcome, or duration of hospital stay.
CONCLUSIONS: Inaccuracies in GA determined by the NBS should be considered when treating extremely premature infants, particularly in decisions to forego or administer intensive care. Refinement of GA scoring systems is needed to optimize clinical benefit.

Entities:  

Mesh:

Year:  1999        PMID: 10431107     DOI: 10.1016/s0022-3476(99)70015-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

1.  Variations in mortality rates among Canadian neonatal intensive care units: interpretation and implications.

Authors:  Jon Tyson; Kathleen Kennedy
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

2.  Approach to infants born at 22 to 24 weeks' gestation: relationship to outcomes of more-mature infants.

Authors:  P Brian Smith; Namasivayam Ambalavanan; Lei Li; C Michael Cotten; Matthew Laughon; Michele C Walsh; Abhik Das; Edward F Bell; Waldemar A Carlo; Barbara J Stoll; Seetha Shankaran; Abbot R Laptook; Rosemary D Higgins; Ronald N Goldberg
Journal:  Pediatrics       Date:  2012-05-28       Impact factor: 7.124

3.  Postnatal Foot Length to Determine Gestational Age: A Pilot Study.

Authors:  Lizelle Van Wyk; Johan Smith
Journal:  J Trop Pediatr       Date:  2016-01-11       Impact factor: 1.165

4.  Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia.

Authors:  Hazem E Hassan; Ahmed A Othman; Natalie D Eddington; Lynn Duffy; Li Xiao; Ken B Waites; David A Kaufman; Karen D Fairchild; Michael L Terrin; Rose M Viscardi
Journal:  J Clin Pharmacol       Date:  2010-11-23       Impact factor: 3.126

5.  Evidence-based treatment decisions for extremely preterm newborns.

Authors:  Nehal A Parikh; Cody Arnold; John Langer; Jon E Tyson
Journal:  Pediatrics       Date:  2010-03-29       Impact factor: 7.124

6.  Outcome trajectories in extremely preterm infants.

Authors:  Namasivayam Ambalavanan; Waldemar A Carlo; Jon E Tyson; John C Langer; Michele C Walsh; Nehal A Parikh; Abhik Das; Krisa P Van Meurs; Seetha Shankaran; Barbara J Stoll; Rosemary D Higgins
Journal:  Pediatrics       Date:  2012-06-11       Impact factor: 7.124

7.  Gestational age and birthweight for risk assessment of neurodevelopmental impairment or death in extremely preterm infants.

Authors:  Ariel A Salas; Waldemar A Carlo; Namasivayam Ambalavanan; Tracy L Nolen; Barbara J Stoll; Abhik Das; Rosemary D Higgins
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2016-02-19       Impact factor: 5.747

8.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Authors:  Matthew M Laughon; John C Langer; Carl L Bose; P Brian Smith; Namasivayam Ambalavanan; Kathleen A Kennedy; Barbara J Stoll; Susie Buchter; Abbot R Laptook; Richard A Ehrenkranz; C Michael Cotten; Deanne E Wilson-Costello; Seetha Shankaran; Krisa P Van Meurs; Alexis S Davis; Marie G Gantz; Neil N Finer; Bradley A Yoder; Roger G Faix; Waldemar A Carlo; Kurt R Schibler; Nancy S Newman; Wade Rich; Abhik Das; Rosemary D Higgins; Michele C Walsh
Journal:  Am J Respir Crit Care Med       Date:  2011-03-04       Impact factor: 21.405

9.  Intensive care for extreme prematurity--moving beyond gestational age.

Authors:  Jon E Tyson; Nehal A Parikh; John Langer; Charles Green; Rosemary D Higgins
Journal:  N Engl J Med       Date:  2008-04-17       Impact factor: 91.245

10.  Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial.

Authors:  Matthew A Rysavy; Lei Li; Jon E Tyson; Erik A Jensen; Abhik Das; Namasivayam Ambalavanan; Matthew M Laughon; Rachel G Greenberg; Ravi M Patel; Claudia Pedroza; Edward F Bell
Journal:  J Pediatr       Date:  2021-05-15       Impact factor: 6.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.